Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Pharming announces First Patient Enrolled in Pediatric Clinical Trial of leniolisib
Pharming Group announces that the first patient has been enrolled in its Phase III clinical […]
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Hemab Therapeutics, a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding […]
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis
Maternova, accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira, a […]
Medivir Announces Pia Baumann as Chief Medical Officer (CMO)
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of […]
TheraVet Signs an International Distribution Agreement for BIOCERA-VET Covering 24 Countries
TheraVet, a pioneering company in the management of osteoarticular diseases in pets, announces the signing […]
Methinks receives CE Marked Certification for AI-based Stroke Triage Software
Methinks, a digital health Company that specializes in early detection and management of Acute Stroke […]
Life Line Screening Appoints Matt Miller as Chief Executive Officer
Life Line Screening, a leading mobile preventative health screening company, announces the appointment of Matt […]
Celltrion and LISCure Biosciences Announce Strategic Collaboration to Develop Novel Microbiome Treatment for Parkinson's Disease
LISCure Biosciences, a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year […]
Maud Sylvain-Neugart, Hoffmann Neopac, On Small Tubes for the Veterinarian Industry
In this video, Maud Sylvain-Neugart, Global Business Development Animal Health at Hoffmann Neopac AG, discusses […]
Azafaros Receives Additional Regulatory Designations for AZ-3102 from FDA, EMA and MHRA
Azafaros today announced its progress in ongoing interactions with Health Authorities regarding its lead drug […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more